Over the next five years, healthcare and life sciences organizations will harness the unique disruptive forces brought about by a digital-first world that will shape many aspects of the industry landscape, from value-based care to prescribing digital therapeutics. A report from IDC Research, the world’s leading market research firm, offers some predictions on how organizations can navigate the winds of change that impact which technologies to adopt, advance capabilities and pursue partnerships.
the findings of the report, IDC FutureScape: 2022 Global Healthcare Industry Predictionswill be highlighted in an upcoming webinar sponsored by Twilio. Webinar scheduled for June 7, 3:30-4:30 pm ET, 12:30-1:30 pm PT.
During a discussion between IDC Research Director Mutaz Shegewi, IDC Research Vice President Dr. Nimita Limaye, and Director of Global Healthcare Services Susan Lucas Collins Twilightregistrants will learn more about:
- Recent Global Healthcare Industry 2022 Predictions Will Drive Healthcare and Life Sciences Organizations Forward in a Digital-First World
- The role that innovative and disruptive technologies will play in helping healthcare become more connected and personalized
- Top business and IT considerations for organizations as industries continue their digital transformation
Twilio is the leading platform for building customer engagement in marketing, service and operations. With a single programmable platform, marketers can optimize communications across any channel, developers can build differentiated customer experiences, and businesses can build lasting relationships with customers. Twilio is headquartered in San Francisco with offices around the world.
Here are the speakers for the webinar:
Susan Lucas Collins, Global Head of Healthcare, Twilio
Susan Collins is a globally recognized expert in healthcare technology and market strategy, regularly speaking at conferences and providing thought leadership for a variety of professional journals and media.
As Twilio’s head of global healthcare, Collins led the company’s healthcare vertical and built Twilio as a leader in iconic brands such as Epic, ZocDoc, Doximity, Doctor On Demand, and MDLive, as well as communications and engagement technologies for numerous hospitals and health systems. Leading suppliers, public health agencies and life sciences organizations.
Previously, she led the innovation and healthcare business units at Salesforce, advising the company’s largest clients on digital transformation, and partnering with leading health tech companies. She also initiated the enterprise health cloud category now utilized by analysts tracking the healthcare CRM space.
Collins also leads organizations within the Yale New Haven and Emory Healthcare Systems, serving as Chief Marketing and Customer Service Officer for Advanced Radiology and Chief Executive Officer for Atlanta Radiology, respectively.
Mutaz Shegewi, Research Director, Provider IT Transformation Strategy, IDC Research
Mutaz Shegewi leads IDC Health Insights’ vendor research practice. He covers topics most relevant to healthcare provider organizations looking to digitally transform and become more digitally capable than their competitors. Mutaz advises executive, clinical and technical leaders of the world’s foremost health information technology supplier and buy-side organizations. He provides data-driven research and thought leadership insights to help address strategic challenges in health information technology and transform decision-making complexity into clarity that reduces costs, improves quality, optimizes access, improves patient safety, and supports patients experience. Mutaz is passionate about enhancing healthcare through the dynamic interrelationship between technology, patients and providers by combining industry, professional, academic, technical and global expertise in healthcare, policy, business, management, research, consulting and medicine system.
Dr. Nimita Limaye, Research Vice President, IDC Health Insights
Dr. Nimita Limaye is Vice President of Research at IDC Health Insights, providing research-based consulting and advisory services, as well as market analysis on key topics related to R&D strategies and technologies for the life sciences industry. She talked about the role of digital transformation in discovery research, the e-clinical ecosystem, the role of NLP, AI, ML, DL, RPA in transforming drug development, precision medicine, pharmaceutical R&D execution, and strategic outsourcing models.
Nimita is an executive business leader with over 20 years of life science leadership experience in the pharmaceutical/CRO/life science technology consulting industry. Passionate about the role of data, technology and analytics in transforming clinical trials and paving the way for future trials. She also serves as a mentor for startups in the Mass Bio Digital Health program.
Nimita holds a Ph.D. in Biotechnology and has chaired the boards of industry associations such as SCDM. She is in active contact with DIA and AMWA. She has hosted numerous conferences, hosted industry roundtables, delivered keynote speeches, hosted webinars, and authored over 40 publications/white papers. Her primary focus is on the role of technology in transforming drug development, virtual clinical trials, patient-centered clinical trials, the use of social media in drug development, risk-based monitoring, and precision medicine.
picture: elenabs, Getty Images
To register for the June 7 webinar, please fill out the form below.
